Sara Imhof, Ph.D., vice president of the focused initiatives team at the North Carolina Biotechnology Center, has been honored by a regional business publication for her inspiring work to lead North ...
Tv Therapeutics' Phase 3 trial for cadisegliatin in type 1 diabetes resumes after FDA lifts hold, with a revised six-month ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback